This study also confirms the importance of an accurate Ki67 evaluation method which can influence the decision to submit ER-positive HER2-negative BC to prognostic molecular platforms as well as the possible usefulness of classical parameters such as tubule formation which can provide additional complementary information t for decision making. This evidence concerns the gene ESR1 and breast cancer.